Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-05-21 @ 11:06 AM
Study NCT ID:
NCT02027935
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2014-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization: